GSK to collaborate with Chinese biotech on COVID-19 vaccine

GlaxoSmithKline has announced plans to collaborate with China’s Xiamen Innovex on a potential vaccine to treat the COVID-19 coronavirus.

US backs first emergency COVID-19 antibody test from Cellex

Apeiron starts mid-stage trial of drug that blocks coronavir...

Some pharmas acting like “toilet roll profiteers” on COVID-1...

COVID-19 patient registry could inform lockdown exit strateg...

Recruitment for a patient registry app for COVID-19 is underway, which could help governments find their way out of lockdown by remote monitoring of symptomatic and asymptomatic patients fo

Coronavirus pharma news roundup – 03/04/20

After pharma ramped up its response to coronaviru